Advancements in Alzheimer's Disease Treatment: Anti-Amyloid Therapies Explained

This chapter explores the recent FDA approvals of anti-amyloid therapies, lukanamab and denanumab, highlighting their efficacy in slowing Alzheimer's disease progression. It also delves into real-world patient and physician experiences with these treatments and discusses potential risks associated with their use.